Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 6/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.54 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4665023 | 0.86 | DPP4 (0.48) | DPP4DPP7OPRM1OPRD1OPRK1 | |
| SCHEMBL8273672 | 0.76 | DPP4 (0.55) | DPP4DPP7 | |
| SCHEMBL4664760 | 0.72 | DPP4 (0.51) | DPP4DPP7ALDH1A1 | |
| SCHEMBL8571009 | 0.72 | PARP1 (0.49) | AGTR2OPRD1OPRK1SIGMAR1MAPK1 | |
| SCHEMBL8571007 | 0.72 | PARP1 (0.49) | AGTR2OPRD1OPRK1SIGMAR1MAPK1 | |
| SCHEMBL5407916 | 0.70 | DPP4 (1.00) | DPP4DPP7 | |
| SCHEMBL3834075 | 0.69 | SIGMAR1 (0.47) | AGTR2SIGMAR1ALDH1A1 | |
| SCHEMBL4982735 | 0.69 | CCR1 (0.52) | SIGMAR1 | |
| SCHEMBL4958145 | 0.69 | DPP4 (0.50) | DPP4DPP7 | |
| SCHEMBL7573297 | 0.68 | SIGMAR1 (0.56) | SIGMAR1MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1604662-A1 | 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft (DE) | 2005-12-14 | — | — | EP | disclosed |